RxNorm Semantic Concepts Index - 319
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "319".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 3190 | Deodorant | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 3190 | Deodorant | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31901 | nitroxoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 31901 | nitroxoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31901 | nitroxoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31901 | nitroxoline | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31901 | nitroxoline | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31903 | Nivalenol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31903 | Nivalenol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31913 | Nicotinamide mononucleotide nucleosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31913 | Nicotinamide mononucleotide nucleosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31913 | Nicotinamide mononucleotide nucleosidase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31913 | Nicotinamide mononucleotide nucleosidase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31913 | Nicotinamide mononucleotide nucleosidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31914 | tiagabine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31914 | tiagabine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 31914 | tiagabine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31914 | tiagabine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 31914 | tiagabine | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31914 | tiagabine | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31930 | nomegestrol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 31930 | nomegestrol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31930 | nomegestrol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 3194 | DCA - Deoxycholic acid | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31945 | vanillyl-N-nonylamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 31945 | vanillyl-N-nonylamide | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31945 | vanillyl-N-nonylamide | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31945 | vanillyl-N-nonylamide | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 31946 | Nonoxinol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31946 | Nonoxinol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31946 | Nonoxinol | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31946 | Nonoxinol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31946 | Nonoxinol | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31946 | Nonoxinol | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31951 | D-nopaline synthase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31951 | D-nopaline synthase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31951 | D-nopaline synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31951 | D-nopaline synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31951 | D-nopaline synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31958 | theodrenaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 3196 | Deoxycytidine kinase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 3196 | Deoxycytidine kinase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31968 | Norbuprenorphine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31968 | Norbuprenorphine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31974 | Norclozapine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31974 | Norclozapine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319779 | Ferula assafoetida resin extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 319779 | Ferula assafoetida resin extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 319780 | chilli pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 319780 | chilli pepper extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 319781 | Eucalyptus extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319781 | Eucalyptus extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319781 | Eucalyptus extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319781 | Eucalyptus extract | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319781 | Eucalyptus extract | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319799 | Erysimum preparation | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319799 | Erysimum preparation | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319799 | Erysimum preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 3198 | dCMP deaminase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 3198 | dCMP deaminase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 3198 | dCMP deaminase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319808 | broccoli preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319810 | cabbage preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319812 | Siberian ginseng preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319815 | Bryonia preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319816 | Urtica preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319818 | Astragalus preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319823 | thyme preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 319824 | gentian preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319826 | beet juice | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 319826 | beet juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 319828 | buckthorn preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319829 | legume preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 31983 | Norethisterone acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 31983 | Norethisterone acetate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31983 | Norethisterone acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 31983 | Norethisterone acetate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 319834 | elderberry preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319837 | gotu kola extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319839 | maca preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 31984 | Norethisterone enantate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 31984 | Norethisterone enantate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31984 | Norethisterone enantate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31984 | Norethisterone enantate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319864 | Cisatracurium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 319864 | Cisatracurium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 319864 | Cisatracurium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 319864 | Cisatracurium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 319864 | Cisatracurium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 319865 | Delestrogen | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319866 | meglumine antimonate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319868 | quinone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 319868 | quinone | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 319875 | Fibrinogen Birmingham | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319875 | Fibrinogen Birmingham | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319876 | Fibrinogen Manchester | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319876 | Fibrinogen Manchester | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319877 | Carbon-sulfur lyase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 319877 | Carbon-sulfur lyase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 319877 | Carbon-sulfur lyase | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31988 | Norphenylephrine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 31988 | Norphenylephrine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31988 | Norphenylephrine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31988 | Norphenylephrine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 31989 | Norfluoxetine | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31989 | Norfluoxetine | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31994 | norgestimate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 31994 | norgestimate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31994 | norgestimate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31994 | norgestimate | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 31994 | norgestimate | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 31995 | Norgestomet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31995 | Norgestomet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 31995 | Norgestomet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 31995 | Norgestomet | Full form of descriptor (FN) | NO |